vimarsana.com

Latest Breaking News On - Kyowa hakko europe - Page 1 : vimarsana.com

NutraIngredients Awards 2024 Winners announced!

NutraIngredients celebrated one decade of annual industry awards last night (May 15) with the winners of this year's competition announced at a VIP Party in Geneva.

Geneva
Genè
Switzerland
Norway
Norwegian
Beta-glucans
Kyowa-hakko-europe
Enovate-biolife
Fitoplancton-marino
Akay-bioactives
Nikki-hancocks
Astareal-astaxanthin

Comple.med Launches the First Food Supplement in Europe Featuring IMMUSE®

Milan, Italy (PRWEB) February 01, 2023 Comple.med, an Italian based company engaged in the field of Complementary Medicines with an emphasis on

Italy
Milan
Lombardia
Italian
Kyowa-hakko-bio-italia
Oksana-ritchie
Kyowa-hakko-europe
Kyowa-hakko
Eugenio-borghi
Kyowa-hakko-bio-co
Kirin-holdings-co-ltd
Complementary-medicines

NutraIngredients Award Winners Europe 2022, Announced Earlier This Month

Dusseldorf, Germany (PRWEB) May 31, 2022 Kyowa Hakko Europe, a leading international health ingredient manufacturer, is pleased to announce this

Kyowa-hakko-bio-italia
Oksana-ritchie
Kyowa-hakko-europe
Kyowa-hakko-bio-co-ltd
Kyowa-hakko-bio-co
Nutraingredients-award-cognizin
Hakko-europe
Nutraingredients-award
Kyowa-hakko
South-european
Kyowa-hakko-bio
Press-release

IMMUSE® Enters European Market Strengthen Your Body's Defenses from the Inside with IMMUSE®

IMMUSE® Enters European Market Strengthen Your Body’s Defenses from the Inside with IMMUSE® Share Article IMMUSE It is a truly unique strain of Lactococcus lactis which activates a broad range of immune cells in our body through the primary activation of pDC cells. This mechanism of action differentiates IMMUSE® from more conventional lactic acid bacteria or other immune ingredients” DUSSELDORF, Germany (PRWEB) April 20, 2021 Researchers at Kirin Holdings, Company Limited, a major Japanese brewing company and a fermentation leader for more than 130 years have found the Lactococcus lactis strain Plasma bacterium and demonstrated its unique ability to stimulate pDC (plasmacytoid dendritic cells), the “commander-in-chief” of the immune system that spurs other immune cells into action.

Japan
United-kingdom
Japanese
British
Kyowa-hakko-bio-italia
Oksana-ritchie
Kyowa-hakko-europe
J-sport-health-sci
Kyowa-hakko-bio-co
Drug-administration
Kirin-holdings-company
Researchers-at-kirin-holdings

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.